SERTRALINE
Strength50 mg
Formoral.solid
50 mg once daily; if the response is inadequate, increase in steps of 50 mg at intervals of at least one week, to a maximum of 200 mg/day - at least 6 months
Adult-only condition - paediatric section not applicable
Sourced preference. This condition's own cited article, Perinatal Depression (NBK519070), makes sertraline a first-line choice for medical therapy; it supports paroxetine only conditionally, for a woman who has previously responded to it.
LUSTRAL ® 50 mg film coated tablets SmPC section 4.2 Posology and method of administration (eMC product 1070)
Perinatal Depression (StatPearls NBK519070) names sertraline a first-line choice for medical therapy, with extensive and reassuring safety research behind it.
- There is an initial transient rise in anxiety or agitation during the first 2 weeks.
- Do not stop abruptly; taper to avoid discontinuation symptoms.
- Monitor a breastfed infant for irritability, poor feeding or sleep disturbance.
- Use in nursing mothers is not recommended unless, in the judgment of the physician, the benefit outweighs the risk.
- Concomitant intake of pimozide is contraindicated (see section 4.5).
| Egyptian brand | Manufacturer | Indicative price |
|---|---|---|
| OPIRALINE 50 MG 20 F.C. TABS. | EL-OBOUR | 29.00 EGP (1.45/unit) |
| AGRELOCIT 50 MG 20 TAB. | MEMPHIS > ATM PHARMACEUTICAL INDUSTRIES | 34.80 EGP (1.74/unit) |
| DEPR-STAT 50MG 10 CAPS. | MEMPHIS | 21.60 EGP (2.16/unit) |
| SESERINE 50MG 30 TAB. | ADWIA | 75.00 EGP (2.50/unit) |
| SERPASS 50MG 30 F.C.TAB. | GLOBAL NAPI PHARMACEUTICALS | 102.00 EGP (3.40/unit) |
| SIRTO 50MG 10 F.C. TABS. | HI-PHARM | 34.00 EGP (3.40/unit) |
| MOODAPEX 50 MG 30 F.C.TAB. | MULTI-APEX | 111.00 EGP (3.70/unit) |
| LUSTRAL 50 MG 20 F.C.TABS. | VIATRIS | 136.00 EGP (6.80/unit) |